China is re-opening to the world after COVID isolation in 2023. Volume based purchasing and Made-in-China (MIC) policy are becoming more important in the public hospital purchases.  This webinar will discuss the ways overseas manufacturers and innovators can shorten time-to-market, reduce cost and increase sales for the increasing significant role of “Made-in-China” policy. The session will also review the key regulatory policies, guideline requirements regarding the policy to understand the requirements, criteria, and benefits. In addition, the different models of made-in-China policy will be discussed. Overseas manufacturers can create a strategy and implementation plan to leverage the “Made-in-China” policy.  The process of utilizing in-China contract manufacturing option will be discussed as well. 

• China MedTech Market High level review
• The background and relevant regulation of Made-in-China (MIC) policy
• Benefits of operating under MAH
• Different models and approaches to achieve MIC policy 
• OEM Responsibilities for Registering New Devices under MAH
• How to choose a CM operating under MAH 
• Key process and steps to establish MIC with contract manufacturer in China 
• The relationship between made-in-China policy with volume-based purchasing
• Case Study